Moderna | MRNA - Sales Revenues


Moderna reported $100M in Sales Revenues for its fiscal quarter ending in June of 2026.





Sales Change Date
Acadia Pharmaceuticals USD 307.96M 39.9M Jun/2026
Agios Pharmaceuticals USD 44.74M 25.94M Jun/2026
Alnylam Pharmaceuticals USD 1.29B 120M Jun/2026
Amgen USD 10.1B 1.48B Jun/2026
Arrowhead Research USD 75.23M 1.49M Jun/2026
Biogen USD 2.74B 490M Jun/2026
BioMarin Pharmaceutical USD 990M 224M Jun/2026
Celltrion KRW 1.24T 90B Jun/2026
Cspc Pharmaceutical CNY 6.47B 355.1M Mar/2026
Deva Holding AS TRY 2.32B 418.58M Sep/2023
Dianthus Therapeutics USD 463K 179K Mar/2026
Divis Laboratories Ltd INR 27.58B 730M Jun/2026
Gilead Sciences USD 7.8B 800M Jun/2026
GlaxoSmithKline GBP 8.41B 781M Jun/2026
Incyte USD 1.67B 400M Jun/2026
Ionis Pharmaceuticals USD 268M 22M Jun/2026
Kangmei Pharma CNY 1.08B 288.27M Mar/2026
Knight Therapeutics CAD 133.11M 11.56M Dec/2025
Laboratorios Farma EUR 448.66M 67.82M Dec/2023
Moderna USD 100M 289M Jun/2026
Organigram Holdings CAD 59.79M 3.74M Mar/2026
Pharma Mar EUR 50M 7.1M Jun/2026
Puma Biotechnology USD 80.54M 33.46M Sep/2024
Qiagen NV USD 463.12M 43.9M Jun/2026
Regeneron Pharmaceuticals USD 4.29B 690M Jun/2026
Sangamo BioSciences USD 356K 125K Jun/2024
Sarepta Therapeutics USD 401.3M 329.5M Jun/2026
Sartorius EUR 911.8M 12.7M Jun/2026
Sino Biopharmaceutical CNY 14.26B 3.31B Dec/2025
Tilray USD 217.51M 74.75M Dec/2025
Ultragenyx Pharmaceutical USD 214M 78M Jun/2026
United Therapeutics USD 783.3M 1.8M Jun/2026
Vertex Pharmaceuticals USD 3.33B 340M Jun/2026
Zealand Pharma A/S 34M 34.92M Mar/2026
Zhangzhou Pientzehuang Pharmaceutical CNY 2.72B 837.63M Mar/2026